[6-K] MEDIROM Healthcare Technologies Inc. American Depositary Share Current Report (Foreign Issuer)
MEDIROM Healthcare Technologies Inc. (NASDAQ: MRM) submitted a routine Form 6-K on 20 June 2025. The filing simply furnishes鈥攔ather than files鈥攁 press release (Exhibit 99.1) that updates the Company鈥檚 Key Performance Indicators (KPIs) for May 2025. Because the information is 鈥渇urnished,鈥� it is not subject to Section 18 liability and will not be automatically incorporated by reference into other SEC documents. No financial statements, earnings results, or transaction details are included, and the Company confirms it continues to report under Form 20-F.
MEDIROM Healthcare Technologies Inc. (NASDAQ: MRM) ha presentato un modulo 6-K ordinario il 20 giugno 2025. La comunicazione fornisce semplicemente鈥攅 non presenta formalmente鈥攗n comunicato stampa (Allegato 99.1) che aggiorna gli Indicatori Chiave di Prestazione (KPI) dell'azienda relativi a maggio 2025. Poich茅 le informazioni sono "fornite" e non "presentate", non sono soggette alla responsabilit脿 ai sensi della Sezione 18 e non saranno automaticamente incorporate per riferimento in altri documenti SEC. Non sono inclusi bilanci, risultati economici o dettagli di transazioni, e l'azienda conferma di continuare a presentare rapporti con il modulo 20-F.
MEDIROM Healthcare Technologies Inc. (NASDAQ: MRM) present贸 un formulario 6-K rutinario el 20 de junio de 2025. La presentaci贸n simplemente proporciona鈥攅n lugar de presentar formalmente鈥攗n comunicado de prensa (Exhibici贸n 99.1) que actualiza los Indicadores Clave de Desempe帽o (KPI) de la Compa帽铆a para mayo de 2025. Debido a que la informaci贸n es "proporcionada" y no "presentada", no est谩 sujeta a la responsabilidad bajo la Secci贸n 18 y no se incorporar谩 autom谩ticamente por referencia en otros documentos de la SEC. No se incluyen estados financieros, resultados de ganancias ni detalles de transacciones, y la Compa帽铆a confirma que contin煤a reportando bajo el Formulario 20-F.
MEDIROM Healthcare Technologies Inc. (NASDAQ: MRM)電� 2025雲� 6鞗� 20鞚� 鞝曣赴 Form 6-K毳� 鞝滌稖頄堨姷雼堧嫟. 鞝滌稖霅� 氍胳劀電� 雼垳頌� 須岇偓鞚� 2025雲� 5鞗� 欤检殧 靹标臣 歆�響�(KPI)毳� 鞐呺嵃鞚错姼頃� 氤措弰鞛愲(觳秬氍胳劀 99.1)毳� 鞝滉车頃橂姅 瓴冹溂搿�, 瓿奠嫕 鞝滌稖鞚� 鞎勲嫏雼堧嫟. "鞝滉车"霅� 鞝曤炒鞚搓赴 霑岆鞐� 靹轨厴 18 毂呾瀯 雽�靸侅澊 鞎勲媹氅�, 雼るジ SEC 氍胳劀鞐� 鞛愲彊鞙茧 彀胳“ 韱淀暕霅橃 鞎婌姷雼堧嫟. 鞛鞝滍憸, 靾橃澋 瓴瓣臣 霕愲姅 瓯半灅 雮挫棴鞚� 韽暔霅橃柎 鞛堨 鞎婌溂氅�, 須岇偓電� 瓿勳啀頃挫劀 Form 20-F鞐� 霐半澕 氤搓碃頃� 瓴冹瀯鞚� 頇曥澑頄堨姷雼堧嫟.
MEDIROM Healthcare Technologies Inc. (NASDAQ : MRM) a soumis un formulaire 6-K de routine le 20 juin 2025. Ce d茅p么t fournit simplement鈥攕ans d茅poser formellement鈥攗n communiqu茅 de presse (Exhibit 99.1) qui met 脿 jour les indicateurs cl茅s de performance (KPI) de la soci茅t茅 pour mai 2025. 脡tant donn茅 que les informations sont 芦 fournies 禄 et non 芦 d茅pos茅es 禄, elles ne sont pas soumises 脿 la responsabilit茅 en vertu de la section 18 et ne seront pas automatiquement incorpor茅es par r茅f茅rence dans d'autres documents de la SEC. Aucun 茅tat financier, r茅sultat de b茅n茅fices ou d茅tail de transaction n鈥檈st inclus, et la soci茅t茅 confirme qu鈥檈lle continue de d茅clarer sous le formulaire 20-F.
MEDIROM Healthcare Technologies Inc. (NASDAQ: MRM) reichte am 20. Juni 2025 routinem盲脽ig ein Formular 6-K ein. Die Einreichung stellt lediglich鈥攕tatt formell einzureichen鈥攅ine Pressemitteilung (Anlage 99.1) bereit, die die wichtigsten Leistungskennzahlen (KPIs) des Unternehmens f眉r Mai 2025 aktualisiert. Da die Informationen "bereitgestellt" und nicht "eingereicht" wurden, unterliegen sie nicht der Haftung gem盲脽 Abschnitt 18 und werden nicht automatisch in andere SEC-Dokumente durch Verweis aufgenommen. Es sind keine Finanzberichte, Gewinnzahlen oder Transaktionsdetails enthalten, und das Unternehmen best盲tigt, weiterhin unter Formular 20-F zu berichten.
- None.
- None.
Insights
TL;DR: Routine 6-K furnishing KPI press release; offers no financial data鈥攏eutral impact on valuation.
The filing鈥檚 sole purpose is to place a May 2025 KPI press release into the public record. With no revenue, earnings, or balance-sheet metrics disclosed, investors gain no quantitative insight. The Company clearly labels the information as 鈥渇urnished,鈥� limiting legal liability and signaling that the content is principally informational. From a capital-markets perspective, the document does not alter earnings forecasts, cash-flow models, or risk assessments. Unless the underlying KPI press release (not provided here) contains material surprises, this 6-K should be viewed as administrative and non-impactful.
TL;DR: Standard compliance filing, reflects adherence to disclosure rules; governance implications minimal.
The Company demonstrates procedural compliance by promptly furnishing KPI updates via Form 6-K. Notably, it specifies that the content is not incorporated by reference, a common practice to manage potential liabilities. No board or executive changes are reported, and there are no new commitments or contingent liabilities. Therefore, corporate governance risk remains unchanged.
MEDIROM Healthcare Technologies Inc. (NASDAQ: MRM) ha presentato un modulo 6-K ordinario il 20 giugno 2025. La comunicazione fornisce semplicemente鈥攅 non presenta formalmente鈥攗n comunicato stampa (Allegato 99.1) che aggiorna gli Indicatori Chiave di Prestazione (KPI) dell'azienda relativi a maggio 2025. Poich茅 le informazioni sono "fornite" e non "presentate", non sono soggette alla responsabilit脿 ai sensi della Sezione 18 e non saranno automaticamente incorporate per riferimento in altri documenti SEC. Non sono inclusi bilanci, risultati economici o dettagli di transazioni, e l'azienda conferma di continuare a presentare rapporti con il modulo 20-F.
MEDIROM Healthcare Technologies Inc. (NASDAQ: MRM) present贸 un formulario 6-K rutinario el 20 de junio de 2025. La presentaci贸n simplemente proporciona鈥攅n lugar de presentar formalmente鈥攗n comunicado de prensa (Exhibici贸n 99.1) que actualiza los Indicadores Clave de Desempe帽o (KPI) de la Compa帽铆a para mayo de 2025. Debido a que la informaci贸n es "proporcionada" y no "presentada", no est谩 sujeta a la responsabilidad bajo la Secci贸n 18 y no se incorporar谩 autom谩ticamente por referencia en otros documentos de la SEC. No se incluyen estados financieros, resultados de ganancias ni detalles de transacciones, y la Compa帽铆a confirma que contin煤a reportando bajo el Formulario 20-F.
MEDIROM Healthcare Technologies Inc. (NASDAQ: MRM)電� 2025雲� 6鞗� 20鞚� 鞝曣赴 Form 6-K毳� 鞝滌稖頄堨姷雼堧嫟. 鞝滌稖霅� 氍胳劀電� 雼垳頌� 須岇偓鞚� 2025雲� 5鞗� 欤检殧 靹标臣 歆�響�(KPI)毳� 鞐呺嵃鞚错姼頃� 氤措弰鞛愲(觳秬氍胳劀 99.1)毳� 鞝滉车頃橂姅 瓴冹溂搿�, 瓿奠嫕 鞝滌稖鞚� 鞎勲嫏雼堧嫟. "鞝滉车"霅� 鞝曤炒鞚搓赴 霑岆鞐� 靹轨厴 18 毂呾瀯 雽�靸侅澊 鞎勲媹氅�, 雼るジ SEC 氍胳劀鞐� 鞛愲彊鞙茧 彀胳“ 韱淀暕霅橃 鞎婌姷雼堧嫟. 鞛鞝滍憸, 靾橃澋 瓴瓣臣 霕愲姅 瓯半灅 雮挫棴鞚� 韽暔霅橃柎 鞛堨 鞎婌溂氅�, 須岇偓電� 瓿勳啀頃挫劀 Form 20-F鞐� 霐半澕 氤搓碃頃� 瓴冹瀯鞚� 頇曥澑頄堨姷雼堧嫟.
MEDIROM Healthcare Technologies Inc. (NASDAQ : MRM) a soumis un formulaire 6-K de routine le 20 juin 2025. Ce d茅p么t fournit simplement鈥攕ans d茅poser formellement鈥攗n communiqu茅 de presse (Exhibit 99.1) qui met 脿 jour les indicateurs cl茅s de performance (KPI) de la soci茅t茅 pour mai 2025. 脡tant donn茅 que les informations sont 芦 fournies 禄 et non 芦 d茅pos茅es 禄, elles ne sont pas soumises 脿 la responsabilit茅 en vertu de la section 18 et ne seront pas automatiquement incorpor茅es par r茅f茅rence dans d'autres documents de la SEC. Aucun 茅tat financier, r茅sultat de b茅n茅fices ou d茅tail de transaction n鈥檈st inclus, et la soci茅t茅 confirme qu鈥檈lle continue de d茅clarer sous le formulaire 20-F.
MEDIROM Healthcare Technologies Inc. (NASDAQ: MRM) reichte am 20. Juni 2025 routinem盲脽ig ein Formular 6-K ein. Die Einreichung stellt lediglich鈥攕tatt formell einzureichen鈥攅ine Pressemitteilung (Anlage 99.1) bereit, die die wichtigsten Leistungskennzahlen (KPIs) des Unternehmens f眉r Mai 2025 aktualisiert. Da die Informationen "bereitgestellt" und nicht "eingereicht" wurden, unterliegen sie nicht der Haftung gem盲脽 Abschnitt 18 und werden nicht automatisch in andere SEC-Dokumente durch Verweis aufgenommen. Es sind keine Finanzberichte, Gewinnzahlen oder Transaktionsdetails enthalten, und das Unternehmen best盲tigt, weiterhin unter Formular 20-F zu berichten.
FAQ
What did MEDIROM (MRM) file with the SEC on 20 June 2025?
Does the Form 6-K include financial statements or earnings results?
Is the information in the 6-K considered "filed" under Section 18?
Which exhibit accompanies the Form 6-K?
Does the filing change MEDIROM鈥檚 reporting framework?
